Home › Funds › D. E. Shaw & Co › MXCT
D. E. Shaw & Co position in MXCT
MAXCYTE INC · Health Care
Latest position (Q1 2026)200.50K sh
Reported value held$140.85K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 45.11K | $315.00K | New |
| Q1 2023 | 66.21K | $327.73K | New |
| Q2 2023 | 48.58K | $222.99K | Reduce |
| Q3 2023 | 25.16K | $78.50K | Reduce |
| Q3 2024 | 24.50K | $95.29K | New |
| Q4 2024 | 108.60K | $451.78K | Add |
| Q1 2025 | 81.76K | $223.22K | Reduce |
| Q2 2025 | 21.55K | $46.98K | Reduce |
| Q3 2025 | 297.64K | $470.27K | Add |
| Q4 2025 | 663.96K | $1.03M | Add |
| Q1 2026 | 200.50K | $140.85K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026
- UBS Group AG 284.27K sh · $349.65K · Q2 2026